Cipla seeks dismissal of Roche's Valcyte infringement suit
This article was originally published in Scrip
Executive Summary
Cipla has filed an application seeking the dismissal ofRoche's suit against it in the Bombay High Court for allegedly infringing on Roche’s patent for Valcyte (valganciclovir) in India. Valcyte is used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.